The fate of transplanted kidneys is substantially influenced by graft quality, with transplantation of kidneys from elderly and expanded criteria donors (ECDs) associated with higher occurrence of delayed graft function, rejection, and inferior long-term outcomes. However, little is known about early molecular fingerprints of these events in different donor categories. Borderline changes represent the most frequent histological finding early after kidney transplantation. Therefore, we examined outcomes and transcriptomic profiles of early-case biopsies diagnosed as borderline changes in different donor categories. In this single-center, retrospective, observational study, we compared midterm outcomes of kidney transplant recipients with early borderline changes as a first pathology between ECD (n = 109), standard criteria donor (SCDs, n = 109), and living donor (LD, n = 51) cohorts. Intragraft gene expression profiling by microarray was performed in part of these ECD, SCD, and LD cohorts. Although 5 year graft survival in patients with borderline changes in early-case biopsies was not influenced by donor category (log-rank P = 0.293), impaired kidney graft function (estimated glomerular filtration rate by Chronic Kidney Disease Epidemiology Collaboration equation) at M3, 1, 2, and 3 years was observed in the ECD cohort (P < 0.001). Graft biopsies from ECD donors had higher vascular intimal fibrosis and arteriolar hyalinosis compared to SCD and LD (P < 0.001), suggesting chronic vascular changes. Increased transcripts typical for ECD, as compared to both LD and SCD, showed enrichment of the inflammatory, defense, and wounding responses and the ECM-receptor interaction pathway. Additionally, increased transcripts in ECD vs. LD showed activation of complement and coagulation and cytokine-cytokine receptor pathways along with platelet activation and cell cycle regulation. Comparative gene expression overlaps of ECD, SCD, and LD using Venn diagrams found 64 up- and 16 down-regulated genes in ECD compared to both LD and SCD. Shared increased transcripts in ECD vs. both SCD and LD included thrombospondin-2 (THBS2), angiopoietin-like 4 (ANGPTL4), collagens (COL6A3, COL1A1), chemokine CCL13, and interleukin IL11, and most significantly, down-regulated transcripts included proline-rich 35 (PRR35) and fibroblast growth factor 9. Early borderline changes in ECD kidney transplantation are characterized by increased regulation of inflammation, extracellular matrix remodeling, and acute kidney injury transcripts in comparison with both LD and SCD grafts.

Department of Computer Science Faculty of Electrical Engineering Czech Technical University Prague Czechia

Department of Genomics Institute of Haematology and Blood Transfusion Prague Czechia

Department of Nephrology Institute for Clinical and Experimental Medicine Prague Czechia

Department of Paediatrics and Adolescent Medicine 1st Faculty of Medicine Charles University Prague Czechia

Department of Pathology Institute for Clinical and Experimental Medicine Prague Czechia

Transplant Laboratory Institute for Clinical and Experimental Medicine Prague Czechia

Zobrazit více v PubMed

DAVIES DF, SHOCK NW. Age changes in glomerular filtration rate, effective renal plasma flow, and tubular excretory capacity in adult males. J Clin Invest. (1950) 29:496–507. 10.1172/JCI102286 PubMed DOI PMC

Hwang JK, Park SC, Kwon KH, Choi BS, Kim JI, Yang CW, et al. . Long-term outcomes of kidney transplantation from expanded criteria deceased donors at a single center: comparison with standard criteria deceased donors. Transplant Proc. (2014) 46:431–6. 10.1016/j.transproceed.2013.11.061 PubMed DOI

Ferreira E, Costa J, Romãozinho C, Santos L, Macário F, Bastos C, et al. . Long-term outcomes of kidney transplantation from expanded-criteria deceased donors: a single-center experience. Transplant Proc. (2017) 49:770–6. 10.1016/j.transproceed.2017.01.051 PubMed DOI

Mueller TF, Reeve J, Jhangri GS, Mengel M, Jacaj Z, Cairo L, et al. . The transcriptome of the implant biopsy identifies donor kidneys at increased risk of delayed graft function. Am J Transplant. (2008) 8:78–85. 10.1111/j.1600-6143.2007.02032.x PubMed DOI

Wohlfahrtova M, Brabcova I, Zelezny F, Balaz P, Janousek L, Honsova E, et al. . Tubular atrophy and low netrin-1 gene expression are associated with delayed kidney allograft function. Transplantation. (2014) 97:176–83. 10.1097/TP.0b013e3182a95d04 PubMed DOI

Balaz P, Rokosny S, Wohlfahrtova M, Wohlfahrt P, Bartonova A, Pokorna E, et al. . Identification of expanded-criteria donor kidney grafts at lower risk of delayed graft function. Transplantation. (2013) 96:633–8. 10.1097/TP.0b013e31829d9225 PubMed DOI

Ko KJ, Kim YH, Kwon KH, Kim MH, Jun KW, Hwang JK, et al. . Kidney transplantation using expanded-criteria deceased donors: a comparison with ideal deceased donors and non-expanded-criteria deceased donors. Transplant Proc. (2018) 50:3222–7. 10.1016/j.transproceed.2018.05.028 PubMed DOI

Hrubá P, Brabcová I, Gueler F, Krejčík Z, Stránecký V, Svobodová E, et al. . Molecular diagnostics identifies risks for graft dysfunction despite borderline histologic changes. Kidney Int. (2015) 88:785–95. 10.1038/ki.2015.211 PubMed DOI

Port FK, Bragg-Gresham JL, Metzger RA, Dykstra DM, Gillespie BW, Young EW, et al. . Donor characteristics associated with reduced graft survival: an approach to expanding the pool of kidney donors. Transplantation. (2002) 74:1281–6. 10.1097/00007890-200211150-00014 PubMed DOI

Rao PS, Ojo A. The alphabet soup of kidney transplantation: SCD, DCD, ECD–fundamentals for the practicing nephrologist. Clin J Am Soc Nephrol. (2009) 4:1827–31. 10.2215/CJN.02270409 PubMed DOI

Edgar R, Domrachev M, Lash AE. Gene expression omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. (2002) 30:207–10. 10.1093/nar/30.1.207 PubMed DOI PMC

Famulski KS, de Freitas DG, Kreepala C, Chang J, Sellares J, Sis B, et al. . Molecular phenotypes of acute kidney injury in kidney transplants. J Am Soc Nephrol. (2012) 23:948–58. 10.1681/ASN.2011090887 PubMed DOI PMC

Cardinal H, Lamarche F, Grondin S, Marsolais P, Lagacé AM, Duca A, et al. . Organ donor management and delayed graft function in kidney transplant recipients: A multicenter retrospective cohort study. Am J Transplant. (2019) 19:277–84. 10.1111/ajt.15127 PubMed DOI

Mas VR, Scian MJ, Archer KJ, Suh JL, David KG, Ren Q, et al. . Pretransplant transcriptome profiles identify among kidneys with delayed graft function those with poorer quality and outcome. Molecular Med. (2011) 17:1311–22. 10.2119/molmed.2011.00159 PubMed DOI PMC

Kotsch K, Kunert K, Merk V, Reutzel-Selke A, Pascher A, Fritzsche F, et al. . Novel markers in zero-hour kidney biopsies indicate graft quality and clinical outcome. Transplantation. (2010) 90:958–65. 10.1097/TP.0b013e3181f546e8 PubMed DOI

Günther J, Resch T, Hackl H, Sattler A, Ebner S, Ritschl PV, et al. . Identification of the activating cytotoxicity receptor NKG2D as a senescence marker in zero-hour kidney biopsies is indicative for clinical outcome. Kidney Int. (2017) 91:1447–63. 10.1016/j.kint.2016.12.018 PubMed DOI

Kreepala C, Famulski KS, Chang J, Halloran PF. Comparing molecular assessment of implantation biopsies with histologic and demographic risk assessment. Am J Transplant. (2013) 13:415–26. 10.1111/ajt.12043 PubMed DOI

Cravedi P, Maggiore U, Mannon RB. Low-density array PCR analysis of reperfusion biopsies: an adjunct to histological analysis. Nephrol Dial Transplant. (2010) 25:4077–86. 10.1093/ndt/gfq297 PubMed DOI PMC

Rödder S, Scherer A, Körner M, Eisenberger U, Hertig A, Raulf F, et al. . Meta-analyses qualify metzincins and related genes as acute rejection markers in renal transplant patients. Am J Transplant. (2010) 10:286–97. 10.1111/j.1600-6143.2009.02928.x PubMed DOI

Schafer S, Viswanathan S, Widjaja AA, Lim WW, Moreno-Moral A, DeLaughter DM, et al. . IL-11 is a crucial determinant of cardiovascular fibrosis. Nature. (2017) 552:110–5. 10.1038/nature24676 PubMed DOI PMC

Li JS, Chen X, Peng L, Wei SY, Zhao SL, Diao TT, et al. . Angiopoietin-like-4, a potential target of tacrolimus, predicts earlier podocyte injury in minimal change disease. PLoS ONE. (2015) 10:e0137049. 10.1371/journal.pone.0137049 PubMed DOI PMC

Wilflingseder J, Sunzenauer J, Toronyi E, Heinzel A, Kainz A, Mayer B., et al. . Molecular pathogenesis of post-transplant acute kidney injury: assessment of whole-genome mRNA and miRNA profiles. PLoS ONE. (2014) 9:e104164. 10.1371/journal.pone.0104164 PubMed DOI PMC

González-Domínguez É, Samaniego R, Flores-Sevilla JL, Campos-Campos SF, Gómez-Campos G, Salas A, et al. . CD163L1 and CLEC5A discriminate subsets of human resident and inflammatory macrophages in vivo. J Leukoc Biol. (2015) 98:453–66. 10.1189/jlb.3HI1114-531R PubMed DOI

Fraser SM, Rajasundaram R, Aldouri A, Farid S, Morris-Stiff G, Baker R, et al. . Acceptable outcome after kidney transplantation using “expanded criteria donor” grafts. Transplantation. (2010) 89:88–96. 10.1097/TP.0b013e3181c343a5 PubMed DOI

Querard AH, Foucher Y, Combescure C, Dantan E, Larmet D, Lorent M., et al. . Comparison of survival outcomes between expanded criteria donor and standard criteria donor kidney transplant recipients: a systematic review and meta-analysis. Transplant Int. (2016) 29:403–15. 10.1111/tri.12736 PubMed DOI

van Ittersum FJ, Hemke AC, Dekker FW, Hilbrands LB, Christiaans MH, Roodnat JI, et al. . Increased risk of graft failure and mortality in dutch recipients receiving an expanded criteria donor kidney transplant. Transplant Int. (2017) 30:14–28. 10.1111/tri.12863 PubMed DOI

Randhawa PS, Minervini MI, Lombardero M, Duquesnoy R, Fung J, Shapiro R, et al. . Biopsy of marginal donor kidneys: correlation of histologic findings with graft dysfunction. Transplantation. (2000) 69:1352–7. 10.1097/00007890-200004150-00024 PubMed DOI

Anglicheau D, Loupy A, Lefaucheur C, Pessione F, Létourneau I, Côté I, et al. . A simple clinico-histopathological composite scoring system is highly predictive of graft outcomes in marginal donors. Am J Transplant. (2008) 8:2325–34. 10.1111/j.1600-6143.2008.02394.x PubMed DOI

Venner JM, Famulski KS, Reeve J, Chang J, Halloran PF. Relationships among injury, fibrosis, and time in human kidney transplants. JCI Insight. (2016) 1:e85323. 10.1172/jci.insight.85323 PubMed DOI PMC